**Author details**

Fatima A. Aldarweesh Department of Pathology, Biological Sciences Division, Blood Bank and Transfusion Service, The University of Chicago, Chicago, IL, USA

\*Address all correspondence to: faldarweesh@uchicago.edu

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**89**

*The Duffy Blood Group System*

[1] Cutbush M, Mollison PL. The Duffy blood group system. Heredity.

**References**

1950;**4**:383-389

1950;**165**:188-189

Elsevier; 2019

2000;**37**:122-129

1989;**264**:13770-13774

2002. pp. 324-341

Genetics. 1995;**10**:224-228

[8] Daniels G. Duffy blood group system. In: Human Blood Groups. 2nd ed. Malden, MA: Blackwell Science;

[9] Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nature

[3] Ikin EW, Mourant AE,

*DOI: http://dx.doi.org/10.5772/intechopen.89952*

[10] Albrey JA, Vincent EE,

Hutchinson J, et al. A new antibody, anti-Fy3, in the Duffy blood group system. Vox Sanguinis. 1971;**20**:29-35

[11] Mallinson G, Soo KS, Schall TJ, Pisacka M, Anstee DJ. Mutations in the erythrocyte chemokine receptor (Duffy) gene: The molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a−b−) phenotype. British Journal of

Haematology. 1995;**90**:823-829

[12] Rios M, Chaudhuri A, Mallinson G, et al. New genotypes in Fy(a−b−) individuals: Nonsense mutations (Trp to stop) in the coding sequence of either FY a or FY B. British Journal of Haematology. 2000;**108**:448-454

[13] Issitt PD, Anstee DJ. Applied Blood Group Serology. 4th ed. Durham, NC: Montgomery Scientific Publications;

[14] Klein HG, Anstee DJ. Mollison's Blood Transfusion in Clinical Medicine.

[15] Olteanu H, Gerber D, Partridge K, Sarode R. Acute hemolytic transfusion

11th ed. Malden, MA: Blackwell

reaction secondary to anti-Fy3. Immunohematology. 2005;**21**:48-52

[16] Behzad O, Lee CL, Gavin J, Marsh WL. A new antierythrocyte antibody in the Duffy system: Anti-Fy4.

Vox Sanguinis. 1973;**24**:337-342

[17] Colledge KI, Pezzulich M, Marsh WL. Anti-Fy5, an antibody disclosing a probable association between the rhesus and Duffy blood group genes. Vox Sanguinis.

[18] Waśniowska K, Blanchard D, Janvier D, et al. Identification of the Fy6

1973;**24**:193-199

Publishing; 2005

1998

[2] Cutbush M, Mollison PL, Parkin DM. A new human blood group. Nature.

Pettenkofer JH, Blumenthal G. Discovery of the expected haemagglutinin, anti-Fyb. Nature. 1951;**168**:1077-1078

[4] Shaz BH, Hillyer CD, Gil MR. Transfusion Medicine and Hemostasis. 3rd ed. Amsterdam, Netherlands:

[5] Pogo AO, Chaudhuri A. The Duffy protein: A malarial and chemokine receptor. Seminars in Hematology.

[6] Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annual Review of Immunology. 2004;**22**:891-928

[7] Chaudhuri A, Zbrzezna V, Johnson C, et al. Purification and characterization of an erythrocyte protein complex carrying Duffy blood group antigenicity. Possible receptor for *Plasmodium vivax* and *Plasmodium knowlesi* malaria parasite. The Journal of Biological Chemistry.
